In the news
Biorce Receives 44 Million to Develop AI for Clinical Trial Platform
La Vanguardia news article about Biorce.
About Biorce
Biorce is an AI healthtech startup, building defensible AI solutions for clinical trial development. Its platform, Aika, is a continuous intelligent layer, from protocol decision to regulatory submission, enabling fewer amendments and a dramatic reduction of cost and time.
Media contact
Lynn Caroline Broeker
PR & Media collaborations
[email protected]
